Why Preserving Remaining Beta Cells Matters in Type 1 Diabetes

Researchers are exploring ways to protect and strengthen the insulin-producing cells that often survive even years after a Type 1 diabetes diagnosis. Understanding what remains could open new treatment possibilities.

Community video — lay discussion, not peer-reviewed research

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cureresearchclinical trial

Key takeaways

Type 1 diabetes doesn't destroy all beta cells at once—many people retain some insulin production years after diagnosis
About 80% of people diagnosed with Type 1 diabetes after age 18 still show detectable insulin production five years later
Scientists are investigating how to support and expand the body's own remaining beta cells rather than replacing them entirely
Both Type 1 and Type 2 diabetes involve beta cell loss, but through different mechanisms

The Beta Cell Survival Question

When someone is diagnosed with Type 1 diabetes, the immune system has attacked insulin-producing beta cells in the pancreas. But here's what may surprise you: not all of these cells are destroyed immediately. Research over the past 15 years has consistently shown that many people retain some beta cell function long after their diagnosis.

This residual insulin production matters because it means there are still working cells in the pancreas that could potentially be supported or expanded.

How Much Insulin Production Remains?

A landmark study from 2009 demonstrated that pancreatic beta cell function persists in many patients living with Type 1 diabetes long-term. More recently, researchers analyzing data from the Type 1 Diabetes Exchange clinic network found that nearly 80% of people diagnosed after age 18 still showed detectable C-peptide (a marker of insulin production) as long as five years after diagnosis.

This finding challenges the older understanding that Type 1 diabetes means complete beta cell failure. The persistence of these cells suggests new therapeutic targets.

A Different Approach: Supporting What Remains

Rather than replacing lost beta cells entirely, some researchers are exploring whether it's possible to promote and protect the insulin-producing cells that patients still have. This approach recognizes a key difference between Type 1 and Type 2 diabetes: while the causes differ (autoimmunity versus insulin resistance), both diseases ultimately involve beta cell loss through programmed cell death.

If scientists can find ways to slow or prevent that cell death in the remaining beta cell population, it might help preserve natural insulin production and improve blood sugar control.

Evidence label

Source: YouTube community video. Evidence type: Community video — lay discussion, not peer-reviewed research. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.